perfluorooctane sulfonic acid has been researched along with Hepatocellular Carcinoma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bjork, JA; Dawson, DA; Krogstad, JO; Wallace, KB | 1 |
| Behr, AC; Braeuning, A; Buhrke, T; Kwiatkowski, A; Luckert, C; Schmidt, FF; Ståhlman, M | 1 |
| Chen, D; Duan, X; Gong, Z; Liu, C; Yang, D; Zhang, Y; Zhu, Y | 1 |
| King-Hudson, TR; Shaw, IC | 1 |
| Hu, DC; Hu, XZ | 1 |
| Butenhoff, JL; Chang, SC; Olsen, GW; Thomford, PJ | 1 |
6 other study(ies) available for perfluorooctane sulfonic acid and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Transcriptional effects of binary combinations of PFAS in FaO cells.
Topics: Alkanesulfonic Acids; Animals; Caprylates; Carcinoma, Hepatocellular; Cell Line, Tumor; Dose-Response Relationship, Drug; Environmental Pollutants; Fluorocarbons; Humans; Liver Neoplasms; PPAR alpha; Rats | 2021 |
Impairment of bile acid metabolism by perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS) in human HepaRG hepatoma cells.
Topics: Alkanesulfonic Acids; Animals; Bile Acids and Salts; Caprylates; Carcinoma, Hepatocellular; Cholesterol; Fluorocarbons; Gene Expression; Hepatocytes; Homeostasis; Humans; Lipid Metabolism; Liver Neoplasms | 2020 |
Perfluorooctane sulfonate promotes doxycycline-induced liver tumor progression in male Kras
Topics: Alkanesulfonic Acids; Animals; Carcinoma, Hepatocellular; Doxycycline; Fluorocarbons; Liver; Liver Neoplasms; Male; Proto-Oncogene Proteins p21(ras); Zebrafish | 2021 |
Minimal risk of PFOS residues in eel to Māori consumers.
Topics: Alkanesulfonic Acids; Animals; Carcinogenicity Tests; Carcinogens; Carcinoma, Hepatocellular; Eels; Environmental Monitoring; Feeding Behavior; Fluorocarbons; Food Contamination; Food Quality; Humans; Liver Neoplasms; Liver Neoplasms, Experimental; New Zealand; No-Observed-Adverse-Effect Level; Rats; Risk Assessment | 2019 |
Effects of perfluorooctanoate and perfluorooctane sulfonate exposure on hepatoma Hep G2 cells.
Topics: Alkanesulfonic Acids; Apoptosis; Caprylates; Carcinoma, Hepatocellular; Catalase; Cell Line, Tumor; Cell Proliferation; Cell Survival; Coloring Agents; Dose-Response Relationship, Drug; Drug Interactions; Environmental Pollutants; Fluorocarbons; Gene Expression; Genes, bcl-2; Glutathione Peroxidase; Glutathione Reductase; Glutathione Transferase; Humans; Liver Neoplasms; Membrane Potential, Mitochondrial; Reactive Oxygen Species; RNA, Messenger; Superoxide Dismutase; Tetrazolium Salts; Thiazoles; Time Factors; Tumor Suppressor Protein p53 | 2009 |
Chronic dietary toxicity and carcinogenicity study with potassium perfluorooctanesulfonate in Sprague Dawley rats.
Topics: Adenoma, Liver Cell; Alkanesulfonic Acids; Animals; Carcinogens; Carcinoma, Hepatocellular; Dose-Response Relationship, Drug; Environmental Pollutants; Female; Fluorocarbons; Hypertrophy; Liver; Liver Neoplasms; Male; Organ Specificity; Random Allocation; Rats; Rats, Sprague-Dawley; Sex Characteristics; Survival Analysis; Toxicity Tests, Chronic; Vacuoles | 2012 |